{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T12:07:18Z","timestamp":1789819638156,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010237","name":"National Society of Genetic Counselors","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010237","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jtct.2026.08.004","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T23:43:03Z","timestamp":1786405383000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Insights to Provider Practice of Germline Testing for Inherited Hematologic Malignancy Predisposition Syndromes to Inform Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4316-8501","authenticated-orcid":false,"given":"Allison S.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"DeSalvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1000-1643","authenticated-orcid":false,"given":"Gabriela","family":"Sanchez-Petitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2026.08.004_bib0001","unstructured":"National Comprehensive Cancer Network, Inc. Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Acute Myeloid Leukemia V.3.2026. Available at: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1446. Accessed May 28, 2026."},{"key":"10.1016\/j.jtct.2026.08.004_bib0002","unstructured":"National Comprehensive Cancer Network, Inc. Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Myelodysplastic Syndromes V.3.2026. Available at: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1446. Accessed May 28, 2026."},{"issue":"1","key":"10.1016\/j.jtct.2026.08.004_bib0003","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13073-019-0664-4","article-title":"Variant Interpretation for Cancer (VIC): a computational tool for assessing clinical impacts of somatic variants","volume":"11","author":"He","year":"2019","journal-title":"Genome Med"},{"issue":"5","key":"10.1016\/j.jtct.2026.08.004_bib0004","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11899-023-00699-3","article-title":"Sporadic and familial acute myeloid leukemia with CEBPA mutations","volume":"18","author":"Yuan","year":"2023","journal-title":"Curr Hematol Malig Rep"},{"issue":"10","key":"10.1016\/j.jtct.2026.08.004_bib0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.19452","article-title":"Yield and utility of germline testing following tumor sequencing in patients with cancer","volume":"3","author":"Lincoln","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.004_bib0006","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/humu.23910","article-title":"A substantial proportion of apparently heterozygous TP53 pathogenic variants detected with a next-generation sequencing hereditary pan-cancer panel are acquired somatically","volume":"41","author":"Coffee","year":"2020","journal-title":"Hum Mutat"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.004_bib0007","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jmoldx.2019.12.003","article-title":"Apparently heterozygous TP53 pathogenic variants may be blood limited in patients undergoing hereditary cancer panel testing","volume":"22","author":"Mester","year":"2020","journal-title":"J Mol Diagn"},{"issue":"10393","key":"10.1016\/j.jtct.2026.08.004_bib0008","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(23)00108-3","article-title":"Acute myeloid leukaemia","volume":"401","author":"DiNardo","year":"2023","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.004_bib0009","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/nyas.12346","article-title":"Familial myelodysplastic syndrome\/acute leukemia syndromes: a review and utility for translational investigations","volume":"1310","author":"West","year":"2014","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"10.1016\/j.jtct.2026.08.004_bib0010","doi-asserted-by":"crossref","DOI":"10.1200\/PO.23.00518","article-title":"Implementation of and systems-level barriers to guideline-driven germline genetic evaluation in the care of patients with myelodysplastic syndrome and acute myeloid leukemia","author":"Banaszak","year":"2024","journal-title":"JCO Precis Oncol"},{"issue":"6","key":"10.1016\/j.jtct.2026.08.004_bib0011","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000321","article-title":"Nordic guidelines for germline predisposition to myeloid neoplasms in adults: recommendations for genetic diagnosis, clinical management and follow-up","volume":"3","author":"Baliakas","year":"2019","journal-title":"HemaSphere"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.004_bib0012","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/hematology.2020006910","article-title":"Identifying potential germline variants from sequencing hematopoietic malignancies","volume":"2020","author":"Kraft","year":"2020","journal-title":"Hematology"},{"issue":"12","key":"10.1016\/j.jtct.2026.08.004_bib0013","doi-asserted-by":"crossref","first-page":"e994","DOI":"10.1016\/S2352-3026(23)00265-X","article-title":"Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT","volume":"10","author":"Gurnari","year":"2023","journal-title":"Lancet Haematol"},{"issue":"2","key":"10.1016\/j.jtct.2026.08.004_bib0014","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s12185-020-02980-0","article-title":"Donor-derived myelodysplastic syndrome after allogeneic stem cell transplantation in a family with germline GATA2 mutation","volume":"113","author":"Sakata","year":"2021","journal-title":"Int J Hematol"},{"issue":"7","key":"10.1016\/j.jtct.2026.08.004_bib0015","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/s41409-019-0691-1","article-title":"The role of germline mutation profiling in the selection of related donors for haematopoietic stem cell transplantation","volume":"55","author":"Zebisch","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2026.08.004_bib0016","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.hoc.2009.01.007","article-title":"Shwachman-Diamond syndrome: a review of the clinical presentation, molecular pathogenesis, diagnosis, and treatment","volume":"23","author":"Burroughs","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"issue":"24","key":"10.1016\/j.jtct.2026.08.004_bib0017","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1182\/blood-2016-01-583625","article-title":"Peffault De Latour R, Soulier J. How I treat MDS and AML in Fanconi anemia","volume":"127","year":"2016","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.jtct.2026.08.004_bib0018","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/blood.2024025131","article-title":"Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT","volume":"145","author":"Gurnari","year":"2025","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtct.2026.08.004_bib0019","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jgc4.1510","article-title":"Incorporating genetic counseling into the evaluation of pediatric bone marrow failure","volume":"31","author":"Schneider","year":"2022","journal-title":"J Genet Couns"},{"issue":"7","key":"10.1016\/j.jtct.2026.08.004_bib0020","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/humu.24374","article-title":"Feasibility and limitations of cultured skin fibroblasts for germline genetic testing in hematologic disorders","volume":"43","author":"DeRoin","year":"2022","journal-title":"Hum Mutat"},{"issue":"4","key":"10.1016\/j.jtct.2026.08.004_bib0021","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10689-021-00263-z","article-title":"Review of guidelines for the identification and clinical care of patients with genetic predisposition for hematological malignancies","volume":"20","author":"Schlegelberger","year":"2021","journal-title":"Fam Cancer"},{"key":"10.1016\/j.jtct.2026.08.004_bib0022","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fped.2017.00252","article-title":"Clinical assessment and diagnosis of germline predisposition to hematopoietic malignancies: The University of Chicago Experience","volume":"5","author":"Desai","year":"2017","journal-title":"Front Pediatr"},{"issue":"11","key":"10.1016\/j.jtct.2026.08.004_bib0023","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.gim.2022.08.010","article-title":"Clinical implementation of genetic testing in adults for hereditary hematologic malignancy syndromes","volume":"24","author":"Ansar","year":"2022","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.jtct.2026.08.004_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2023.100812","article-title":"Clinical, technical, and environmental biases influencing equitable access to clinical genetics\/genomics testing: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"25","author":"Matalon","year":"2023","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.jtct.2026.08.004_bib0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.6004\/jnccn.2017.0022","article-title":"Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative","volume":"15","author":"Trosman","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.004_bib0026","doi-asserted-by":"crossref","DOI":"10.1200\/EDBK_432218","article-title":"Germline predisposition in hematologic malignancies: testing, management, and implications","volume":"44","author":"Godley","year":"2024","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"7","key":"10.1016\/j.jtct.2026.08.004_bib0027","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3390\/jpm12071146","article-title":"Genetic testing and\/or counseling for colorectal cancer by health insurance type","volume":"12","author":"Mansur","year":"2022","journal-title":"J Pers Med"},{"issue":"15","key":"10.1016\/j.jtct.2026.08.004_bib0028","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1002\/cncr.31316","article-title":"Genetic testing for hereditary prostate cancer: Current status and limitations","volume":"124","author":"Zhen","year":"2018","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.jtct.2026.08.004_bib0029","first-page":"8","article-title":"A genetic revolution: cancer genetic testing and counseling","volume":"106","author":"Ebott","year":"2023","journal-title":"R I Med J"},{"issue":"6","key":"10.1016\/j.jtct.2026.08.004_bib0030","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a036541","article-title":"Cancer Genetic Counseling\u2014Current Practice and Future Challenges","volume":"10","author":"Schienda","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"12","key":"10.1016\/j.jtct.2026.08.004_bib0031","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1177\/00031348231175097","article-title":"Pivotal role of genetic counselors in the uptake of germline genetic testing in non-metastatic breast cancer and the impact of testing on surgical decision making","volume":"89","author":"Erali","year":"2023","journal-title":"Am Surg"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.004_bib0032","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5603\/NJO.2022.0030","article-title":"The role of genetic counselling in oncology","volume":"72","author":"Stembalska","year":"2022","journal-title":"Nowotw J Oncol"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.004_bib0033","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41409-022-01828-x","article-title":"Clinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipients","volume":"58","author":"Lahtinen","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.004_bib0034","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.1016\/j.gim.2022.01.561","article-title":"OP010: Germline genetic testing outcomes in a cohort of pediatric patients with hematological malignancies or primary immunodeficiencies undergoing bone marrow transplantation","volume":"24","author":"Mostafavi","year":"2022","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.004_bib0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10897-017-0067-x","article-title":"A rapid systematic review of outcomes studies in genetic counseling","volume":"26","author":"Madlensky","year":"2017","journal-title":"J Genet Couns"},{"issue":"Supplement 1","key":"10.1016\/j.jtct.2026.08.004_bib0036","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2024-210448","article-title":"Outcomes of germline genetic testing in children with hematologic malignancies undergoing allogeneic transplantation","volume":"144","author":"Pandey","year":"2024","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.004_bib0037","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gim.2021.11.002","article-title":"Points to consider to avoid unfair discrimination and the misuse of genetic information: a statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"24","author":"Seaver","year":"2022","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.004_bib0038","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1097\/AOG.0000000000006131","article-title":"Ethical Considerations for Genetic Testing and Counseling in Obstetrics and Gynecology","volume":"147","year":"2026","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.jtct.2026.08.004_bib0039","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1200\/JCO.23.02225","article-title":"Germline testing in patients with breast cancer: ASCO\u2013Society of Surgical Oncology Guideline","volume":"42","author":"Bedrosian","year":"2024","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.jtct.2026.08.004_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2026.102537","article-title":"A scalable new model of germline cancer genomic care delivery: Assessing psychological outcomes","volume":"28","author":"Solomon","year":"2026","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.jtct.2026.08.004_bib0041","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/YCO.0000000000000573","article-title":"Genetic testing for Alzheimer\u2019s disease: trends, challenges and ethical considerations","volume":"33","author":"Renter\u00eda","year":"2020","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.jtct.2026.08.004_bib0042","unstructured":"American Cancer Society. Understanding Genetic Testing for Cancer Risk. Available at:https:\/\/www.cancer.org\/cancer\/risk-prevention\/genetics\/genetic-testing-for-cancer-risk\/understanding-genetic-testing-for-cancer.html. Accessed May 8, 2026."},{"issue":"2","key":"10.1016\/j.jtct.2026.08.004_bib0043","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10897-007-9126-z","article-title":"Genetics education for health professionals: a context","volume":"17","author":"McInerney","year":"2008","journal-title":"J Genet Couns"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.004_bib0044","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12909-017-0982-4","article-title":"Increasing confidence and changing behaviors in primary care providers engaged in genetic counselling","volume":"17","author":"Wilkes","year":"2017","journal-title":"BMC Med Educ"},{"issue":"2","key":"10.1016\/j.jtct.2026.08.004_bib0045","article-title":"P550: Genetic counselors\u2019 perspectives on shifting emphasis to post-test counseling following germline genetic testing in cancer care","author":"Stopfer","year":"2024","journal-title":"Genet Med Open"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726006081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726006081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T11:25:29Z","timestamp":1789817129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726006081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":45,"alternative-id":["S2666636726006081"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.08.004","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights to Provider Practice of Germline Testing for Inherited Hematologic Malignancy Predisposition Syndromes to Inform Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}